Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Martin Boegemann, Sara Khaksar, Guillaume Bera, Alison Birtle, Catherine Dopchie, Louis-Marie Dourthe, Els Everaert, Martin Hatzinger, Dirko Hercher, Werner Hilgers, Geoffrey Matus, Laura Garcia Alvarez, Laurent Antoni, Martin Lukac, Geneviève Pissart, Paul Robinson, Tony Elliott

ABSTRACT

BACKGROUND: With the recent introduction of novel treatment options, real-world data from patients with metastatic castration-resistant prostate cancer (mCRPC) are required to better understand the impact on routine clinical practice. This study primarily aimed to describe the time to treatment failure (TTF) of mCRPC patients treated with abiraterone acetate plus prednisone or the corticosteroid of choice (AAP) in the pre-chemotherapy setting. Other relevant outcomes, clinical and treatment characteristics of these patients were also evaluated. METHODS: This retrospective, observational study collected data from chemotherapy-naïve mCRPC patients treated with AAP from four European countries. Kaplan-Meier curves were used to estimate TTF, progression-free survival (PFS), and time to first skeletal-related event. The impact of baseline characteristics on TTF and PFS was explored using univariate and multivariate Cox proportional hazard models. Log-rank test was used to assess the potential role of duration of response to ADT in predicting response to AAP treatment. RESULTS: Data from 481 eligible patients (Belgium: 68; France: 61; Germany: 150; UK: 202) were analysed. At AAP initiation, the median age of patients was 75.0 years (interquartile range [IQR]: 69.0-81.0), and the median PSA was 56.2 ng/mL (IQR: 22.2-133.1), with over 50% of patients presenting an ECOG score of 0 or 1. Visceral metastases were present in 7.5% of patients; an exclusion criterion in the COU-AA-302 clinical trial. The median TTF with AAP was 10.0 months (95%CI: 9.2-11.1) and the median PFS was 10.8 months (95%CI: 9.6-11.8). Shorter TTF was significantly associated with higher ALP (> 119 units/L), higher PSA (> 56.2 ng/mL), or poorer ECOG PS scores at AAP initiation (p < 0.05). Patients with longer duration of response to ADT (≥12 months) presented longer TTF and longer time to progression (p < 0.0001). CONCLUSIONS: This European real-world study provides valuable insights into the characteristics, treatment, and outcomes of chemotherapy-naïve patients with mCRPC who received AAP in routine clinical practice. Treatment effectiveness of AAP in the real-world is maintained despite patients having poorer clinical features at initiation than those observed in the COU-AA-302 trial population. More... »

PAGES

60

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-019-5280-6

DOI

http://dx.doi.org/10.1186/s12885-019-5280-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111405173

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30642291


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University Hospital M\u00fcnster", 
          "id": "https://www.grid.ac/institutes/grid.16149.3b", 
          "name": [
            "Department of Urology, University of Muenster Medical Center, Albert-Schweitzer-Campus 1, GB A1, D-48149, Muenster, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boegemann", 
        "givenName": "Martin", 
        "id": "sg:person.01365425734.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365425734.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Surrey County Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416224.7", 
          "name": [
            "St Luke\u2019s Cancer Centre, The Royal Surrey County Hospital, Guildford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khaksar", 
        "givenName": "Sara", 
        "id": "sg:person.01251556425.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251556425.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Groupe Hospitalier Bretagne Sud, H\u00f4pital du Scorff, Lorient, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bera", 
        "givenName": "Guillaume", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Manchester", 
          "id": "https://www.grid.ac/institutes/grid.5379.8", 
          "name": [
            "Rosemere Cancer Centre, Royal Preston Hospital & University of Manchester, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Birtle", 
        "givenName": "Alison", 
        "id": "sg:person.01134220445.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134220445.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "CHWapi site IMC, Tournai, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dopchie", 
        "givenName": "Catherine", 
        "id": "sg:person.01213006401.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213006401.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Clinique Saint Anne, Strasbourg, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dourthe", 
        "givenName": "Louis-Marie", 
        "id": "sg:person.0645237204.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645237204.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "AZ Nikolaas, Sint Niklaas, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Everaert", 
        "givenName": "Els", 
        "id": "sg:person.01023515502.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023515502.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Agaplesion Markus Hospital", 
          "id": "https://www.grid.ac/institutes/grid.491941.0", 
          "name": [
            "Agaplesion Markus Hospital, Frankfurt, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hatzinger", 
        "givenName": "Martin", 
        "id": "sg:person.013416351367.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013416351367.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Refrath Urological Center, Bergisch Gladbach, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hercher", 
        "givenName": "Dirko", 
        "id": "sg:person.015606672767.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015606672767.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Sainte Catherine", 
          "id": "https://www.grid.ac/institutes/grid.482015.a", 
          "name": [
            "Institut Sainte Catherine, Avignon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hilgers", 
        "givenName": "Werner", 
        "id": "sg:person.01276310356.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276310356.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "CHC Cliniques Saint Joseph, Li\u00e8ge, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matus", 
        "givenName": "Geoffrey", 
        "id": "sg:person.010476562567.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010476562567.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "IQVIA, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alvarez", 
        "givenName": "Laura Garcia", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen (Belgium)", 
          "id": "https://www.grid.ac/institutes/grid.419619.2", 
          "name": [
            "Janssen Pharmaceutica NV, Beerse, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Antoni", 
        "givenName": "Laurent", 
        "id": "sg:person.013600713167.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013600713167.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "PAREXEL International, Prague, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lukac", 
        "givenName": "Martin", 
        "id": "sg:person.010661124367.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010661124367.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen (Belgium)", 
          "id": "https://www.grid.ac/institutes/grid.419619.2", 
          "name": [
            "Janssen Pharmaceutica NV, Beerse, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pissart", 
        "givenName": "Genevi\u00e8ve", 
        "id": "sg:person.015771234567.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015771234567.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "European Medicines Agency", 
          "id": "https://www.grid.ac/institutes/grid.452397.e", 
          "name": [
            "Janssen EMEA, London, High Wycombe, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Robinson", 
        "givenName": "Paul", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "The Christie Hospital, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Elliott", 
        "givenName": "Tony", 
        "id": "sg:person.0725734372.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725734372.26"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)71205-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013268426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2015.06.128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023927743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2016.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027585737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdv257", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029354653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12894-016-0132-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030036152", 
          "https://doi.org/10.1186/s12894-016-0132-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1209096", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034543175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urolonc.2016.02.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051439111"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18553/jmcp.2016.16233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068661561"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: With the recent introduction of novel treatment options, real-world data from patients with metastatic castration-resistant prostate cancer (mCRPC) are required to better understand the impact on routine clinical practice. This study primarily aimed to describe the time to treatment failure (TTF) of mCRPC patients treated with abiraterone acetate plus prednisone or the corticosteroid of choice (AAP) in the pre-chemotherapy setting. Other relevant outcomes, clinical and treatment characteristics of these patients were also evaluated.\nMETHODS: This retrospective, observational study collected data from chemotherapy-na\u00efve mCRPC patients treated with AAP from four European countries. Kaplan-Meier curves were used to estimate TTF, progression-free survival (PFS), and time to first skeletal-related event. The impact of baseline characteristics on TTF and PFS was explored using univariate and multivariate Cox proportional hazard models. Log-rank test was used to assess the potential role of duration of response to ADT in predicting response to AAP treatment.\nRESULTS: Data from 481 eligible patients (Belgium: 68; France: 61; Germany: 150; UK: 202) were analysed. At AAP initiation, the median age of patients was 75.0\u2009years (interquartile range [IQR]: 69.0-81.0), and the median PSA was 56.2\u2009ng/mL (IQR: 22.2-133.1), with over 50% of patients presenting an ECOG score of 0 or 1. Visceral metastases were present in 7.5% of patients; an exclusion criterion in the COU-AA-302 clinical trial. The median TTF with AAP was 10.0\u2009months (95%CI: 9.2-11.1) and the median PFS was 10.8\u2009months (95%CI: 9.6-11.8). Shorter TTF was significantly associated with higher ALP (>\u2009119\u2009units/L), higher PSA (>\u200956.2\u2009ng/mL), or poorer ECOG PS scores at AAP initiation (p\u00a0<\u20090.05). Patients with longer duration of response to ADT (\u226512\u2009months) presented longer TTF and longer time to progression (p\u00a0<\u20090.0001).\nCONCLUSIONS: This European real-world study provides valuable insights into the characteristics, treatment, and outcomes of chemotherapy-na\u00efve patients with mCRPC who received AAP in routine clinical practice. Treatment effectiveness of AAP in the real-world is maintained despite patients having poorer clinical features at initiation than those observed in the COU-AA-302 trial population.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-019-5280-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study", 
    "pagination": "60", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "638ca1b9d73a769341446df2f17119e89505d83569aa139f42fa8639a21e3b6a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30642291"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-019-5280-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111405173"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-019-5280-6", 
      "https://app.dimensions.ai/details/publication/pub.1111405173"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T08:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000320_0000000320/records_101405_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12885-019-5280-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5280-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5280-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5280-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5280-6'


 

This table displays all metadata directly associated to this object as RDF triples.

239 TRIPLES      21 PREDICATES      37 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-019-5280-6 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N1583611683a54cdcb9fff8912ca135b7
4 schema:citation sg:pub.10.1186/s12894-016-0132-z
5 https://doi.org/10.1016/j.ejca.2015.06.128
6 https://doi.org/10.1016/j.eururo.2016.08.002
7 https://doi.org/10.1016/j.urolonc.2016.02.013
8 https://doi.org/10.1016/s1470-2045(14)71205-7
9 https://doi.org/10.1056/nejmoa1209096
10 https://doi.org/10.1093/annonc/mdv257
11 https://doi.org/10.18553/jmcp.2016.16233
12 schema:datePublished 2019-12
13 schema:datePublishedReg 2019-12-01
14 schema:description BACKGROUND: With the recent introduction of novel treatment options, real-world data from patients with metastatic castration-resistant prostate cancer (mCRPC) are required to better understand the impact on routine clinical practice. This study primarily aimed to describe the time to treatment failure (TTF) of mCRPC patients treated with abiraterone acetate plus prednisone or the corticosteroid of choice (AAP) in the pre-chemotherapy setting. Other relevant outcomes, clinical and treatment characteristics of these patients were also evaluated. METHODS: This retrospective, observational study collected data from chemotherapy-naïve mCRPC patients treated with AAP from four European countries. Kaplan-Meier curves were used to estimate TTF, progression-free survival (PFS), and time to first skeletal-related event. The impact of baseline characteristics on TTF and PFS was explored using univariate and multivariate Cox proportional hazard models. Log-rank test was used to assess the potential role of duration of response to ADT in predicting response to AAP treatment. RESULTS: Data from 481 eligible patients (Belgium: 68; France: 61; Germany: 150; UK: 202) were analysed. At AAP initiation, the median age of patients was 75.0 years (interquartile range [IQR]: 69.0-81.0), and the median PSA was 56.2 ng/mL (IQR: 22.2-133.1), with over 50% of patients presenting an ECOG score of 0 or 1. Visceral metastases were present in 7.5% of patients; an exclusion criterion in the COU-AA-302 clinical trial. The median TTF with AAP was 10.0 months (95%CI: 9.2-11.1) and the median PFS was 10.8 months (95%CI: 9.6-11.8). Shorter TTF was significantly associated with higher ALP (> 119 units/L), higher PSA (> 56.2 ng/mL), or poorer ECOG PS scores at AAP initiation (p < 0.05). Patients with longer duration of response to ADT (≥12 months) presented longer TTF and longer time to progression (p < 0.0001). CONCLUSIONS: This European real-world study provides valuable insights into the characteristics, treatment, and outcomes of chemotherapy-naïve patients with mCRPC who received AAP in routine clinical practice. Treatment effectiveness of AAP in the real-world is maintained despite patients having poorer clinical features at initiation than those observed in the COU-AA-302 trial population.
15 schema:genre research_article
16 schema:inLanguage en
17 schema:isAccessibleForFree true
18 schema:isPartOf N02d9e91433d94f0abe9f589c397784ed
19 N5be9e7c24c0a437c9e813f763118509c
20 sg:journal.1024632
21 schema:name Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study
22 schema:pagination 60
23 schema:productId N0d8efd69bd984dbab8a8e5c6efc34587
24 N1c10263499ca4070a0c968ceb4db0c21
25 N244d0ab6b4a44d83be40a313c9315590
26 N2b11c9586d83433d89dfdb5485ff781a
27 Nf69840f7198a472298bf745864d5fb27
28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111405173
29 https://doi.org/10.1186/s12885-019-5280-6
30 schema:sdDatePublished 2019-04-11T08:41
31 schema:sdLicense https://scigraph.springernature.com/explorer/license/
32 schema:sdPublisher N20190f74e828447ba802a74c5bfcf925
33 schema:url https://link.springer.com/10.1186%2Fs12885-019-5280-6
34 sgo:license sg:explorer/license/
35 sgo:sdDataset articles
36 rdf:type schema:ScholarlyArticle
37 N02d9e91433d94f0abe9f589c397784ed schema:volumeNumber 19
38 rdf:type schema:PublicationVolume
39 N06e9c701a53846aca21cfcdcc5bd99cb schema:name CHC Cliniques Saint Joseph, Liège, Belgium
40 rdf:type schema:Organization
41 N0d8efd69bd984dbab8a8e5c6efc34587 schema:name readcube_id
42 schema:value 638ca1b9d73a769341446df2f17119e89505d83569aa139f42fa8639a21e3b6a
43 rdf:type schema:PropertyValue
44 N0ddeab29a65a421b83af7b780df5c235 rdf:first sg:person.015606672767.45
45 rdf:rest Nb240a1a128ff4f53a1b7db8b9d5182aa
46 N10fc4c1fd6144bfe9fbb7132ff72193a rdf:first sg:person.013416351367.20
47 rdf:rest N0ddeab29a65a421b83af7b780df5c235
48 N1583611683a54cdcb9fff8912ca135b7 rdf:first sg:person.01365425734.21
49 rdf:rest N33fde51c6fc94518920a04fdd036ff89
50 N1c10263499ca4070a0c968ceb4db0c21 schema:name pubmed_id
51 schema:value 30642291
52 rdf:type schema:PropertyValue
53 N20190f74e828447ba802a74c5bfcf925 schema:name Springer Nature - SN SciGraph project
54 rdf:type schema:Organization
55 N20969c8b6a5546bfa356ed53adbd15e9 rdf:first Naa1fe064da87409da0a4794120b3544e
56 rdf:rest Nfd86c14ffd0747f08e2d97b2ed348c41
57 N244d0ab6b4a44d83be40a313c9315590 schema:name dimensions_id
58 schema:value pub.1111405173
59 rdf:type schema:PropertyValue
60 N25089caf657d4a989c92108e815ad453 rdf:first sg:person.01023515502.27
61 rdf:rest N10fc4c1fd6144bfe9fbb7132ff72193a
62 N2b11c9586d83433d89dfdb5485ff781a schema:name nlm_unique_id
63 schema:value 100967800
64 rdf:type schema:PropertyValue
65 N2dc472eca69a498fb08502265719a104 schema:affiliation N6b3e1aac04d44acf9c5469377956f17d
66 schema:familyName Alvarez
67 schema:givenName Laura Garcia
68 rdf:type schema:Person
69 N33fde51c6fc94518920a04fdd036ff89 rdf:first sg:person.01251556425.56
70 rdf:rest Nb1d3137aa29a4aa19f3d3532ecd78d74
71 N512627e774c142869627606b21d5d247 rdf:first sg:person.01213006401.17
72 rdf:rest Nd764a5e56308456e8a40453e2f5bb5f0
73 N51b0e9bdfd6f4033b6cdfb42fa9e5e93 schema:name AZ Nikolaas, Sint Niklaas, Belgium
74 rdf:type schema:Organization
75 N5be9e7c24c0a437c9e813f763118509c schema:issueNumber 1
76 rdf:type schema:PublicationIssue
77 N5c28ed7543ea4207bc65c564e9bff091 rdf:first sg:person.013600713167.56
78 rdf:rest Nd7ff9e55f2d64805a5bf57f40fc1e1cb
79 N6b3e1aac04d44acf9c5469377956f17d schema:name IQVIA, Barcelona, Spain
80 rdf:type schema:Organization
81 N804f138b96e5430aae947f01589b706d schema:name Refrath Urological Center, Bergisch Gladbach, Germany
82 rdf:type schema:Organization
83 N90aab67b472e4a45979811f07fa67da8 rdf:first sg:person.010476562567.29
84 rdf:rest Nee88960580b648f3bc582e8a560cb36c
85 Na1ad3053139d4ae98b1504d50fd6719e rdf:first sg:person.015771234567.18
86 rdf:rest N20969c8b6a5546bfa356ed53adbd15e9
87 Na5da36d3ec73426fb9a82964bf06d904 schema:name PAREXEL International, Prague, Czech Republic
88 rdf:type schema:Organization
89 Naa1fe064da87409da0a4794120b3544e schema:affiliation https://www.grid.ac/institutes/grid.452397.e
90 schema:familyName Robinson
91 schema:givenName Paul
92 rdf:type schema:Person
93 Nb1d3137aa29a4aa19f3d3532ecd78d74 rdf:first Nc32934d39afc41bf956e1689eb94f111
94 rdf:rest Ne9020b705c7a4187b992d63e817c61f5
95 Nb240a1a128ff4f53a1b7db8b9d5182aa rdf:first sg:person.01276310356.19
96 rdf:rest N90aab67b472e4a45979811f07fa67da8
97 Nb766a1aecaa745ab94bd5fc64f18338a schema:name CHWapi site IMC, Tournai, Belgium
98 rdf:type schema:Organization
99 Nc32934d39afc41bf956e1689eb94f111 schema:affiliation Ncadba01dd2444892b491c2a3e5e96de5
100 schema:familyName Bera
101 schema:givenName Guillaume
102 rdf:type schema:Person
103 Ncadba01dd2444892b491c2a3e5e96de5 schema:name Groupe Hospitalier Bretagne Sud, Hôpital du Scorff, Lorient, France
104 rdf:type schema:Organization
105 Nd764a5e56308456e8a40453e2f5bb5f0 rdf:first sg:person.0645237204.25
106 rdf:rest N25089caf657d4a989c92108e815ad453
107 Nd7ff9e55f2d64805a5bf57f40fc1e1cb rdf:first sg:person.010661124367.29
108 rdf:rest Na1ad3053139d4ae98b1504d50fd6719e
109 Ne9020b705c7a4187b992d63e817c61f5 rdf:first sg:person.01134220445.33
110 rdf:rest N512627e774c142869627606b21d5d247
111 Nee88960580b648f3bc582e8a560cb36c rdf:first N2dc472eca69a498fb08502265719a104
112 rdf:rest N5c28ed7543ea4207bc65c564e9bff091
113 Nf4b1a035e0d44b41b29df3e0f0f11713 schema:name Clinique Saint Anne, Strasbourg, France
114 rdf:type schema:Organization
115 Nf69840f7198a472298bf745864d5fb27 schema:name doi
116 schema:value 10.1186/s12885-019-5280-6
117 rdf:type schema:PropertyValue
118 Nfd86c14ffd0747f08e2d97b2ed348c41 rdf:first sg:person.0725734372.26
119 rdf:rest rdf:nil
120 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
121 schema:name Medical and Health Sciences
122 rdf:type schema:DefinedTerm
123 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
124 schema:name Clinical Sciences
125 rdf:type schema:DefinedTerm
126 sg:journal.1024632 schema:issn 1471-2407
127 schema:name BMC Cancer
128 rdf:type schema:Periodical
129 sg:person.01023515502.27 schema:affiliation N51b0e9bdfd6f4033b6cdfb42fa9e5e93
130 schema:familyName Everaert
131 schema:givenName Els
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023515502.27
133 rdf:type schema:Person
134 sg:person.010476562567.29 schema:affiliation N06e9c701a53846aca21cfcdcc5bd99cb
135 schema:familyName Matus
136 schema:givenName Geoffrey
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010476562567.29
138 rdf:type schema:Person
139 sg:person.010661124367.29 schema:affiliation Na5da36d3ec73426fb9a82964bf06d904
140 schema:familyName Lukac
141 schema:givenName Martin
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010661124367.29
143 rdf:type schema:Person
144 sg:person.01134220445.33 schema:affiliation https://www.grid.ac/institutes/grid.5379.8
145 schema:familyName Birtle
146 schema:givenName Alison
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134220445.33
148 rdf:type schema:Person
149 sg:person.01213006401.17 schema:affiliation Nb766a1aecaa745ab94bd5fc64f18338a
150 schema:familyName Dopchie
151 schema:givenName Catherine
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213006401.17
153 rdf:type schema:Person
154 sg:person.01251556425.56 schema:affiliation https://www.grid.ac/institutes/grid.416224.7
155 schema:familyName Khaksar
156 schema:givenName Sara
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251556425.56
158 rdf:type schema:Person
159 sg:person.01276310356.19 schema:affiliation https://www.grid.ac/institutes/grid.482015.a
160 schema:familyName Hilgers
161 schema:givenName Werner
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276310356.19
163 rdf:type schema:Person
164 sg:person.013416351367.20 schema:affiliation https://www.grid.ac/institutes/grid.491941.0
165 schema:familyName Hatzinger
166 schema:givenName Martin
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013416351367.20
168 rdf:type schema:Person
169 sg:person.013600713167.56 schema:affiliation https://www.grid.ac/institutes/grid.419619.2
170 schema:familyName Antoni
171 schema:givenName Laurent
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013600713167.56
173 rdf:type schema:Person
174 sg:person.01365425734.21 schema:affiliation https://www.grid.ac/institutes/grid.16149.3b
175 schema:familyName Boegemann
176 schema:givenName Martin
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365425734.21
178 rdf:type schema:Person
179 sg:person.015606672767.45 schema:affiliation N804f138b96e5430aae947f01589b706d
180 schema:familyName Hercher
181 schema:givenName Dirko
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015606672767.45
183 rdf:type schema:Person
184 sg:person.015771234567.18 schema:affiliation https://www.grid.ac/institutes/grid.419619.2
185 schema:familyName Pissart
186 schema:givenName Geneviève
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015771234567.18
188 rdf:type schema:Person
189 sg:person.0645237204.25 schema:affiliation Nf4b1a035e0d44b41b29df3e0f0f11713
190 schema:familyName Dourthe
191 schema:givenName Louis-Marie
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645237204.25
193 rdf:type schema:Person
194 sg:person.0725734372.26 schema:affiliation https://www.grid.ac/institutes/grid.415720.5
195 schema:familyName Elliott
196 schema:givenName Tony
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725734372.26
198 rdf:type schema:Person
199 sg:pub.10.1186/s12894-016-0132-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1030036152
200 https://doi.org/10.1186/s12894-016-0132-z
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.ejca.2015.06.128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023927743
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/j.eururo.2016.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027585737
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/j.urolonc.2016.02.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051439111
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/s1470-2045(14)71205-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013268426
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1056/nejmoa1209096 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034543175
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1093/annonc/mdv257 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029354653
213 rdf:type schema:CreativeWork
214 https://doi.org/10.18553/jmcp.2016.16233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068661561
215 rdf:type schema:CreativeWork
216 https://www.grid.ac/institutes/grid.16149.3b schema:alternateName University Hospital Münster
217 schema:name Department of Urology, University of Muenster Medical Center, Albert-Schweitzer-Campus 1, GB A1, D-48149, Muenster, Germany
218 rdf:type schema:Organization
219 https://www.grid.ac/institutes/grid.415720.5 schema:alternateName The Christie Hospital
220 schema:name The Christie Hospital, Manchester, UK
221 rdf:type schema:Organization
222 https://www.grid.ac/institutes/grid.416224.7 schema:alternateName Royal Surrey County Hospital
223 schema:name St Luke’s Cancer Centre, The Royal Surrey County Hospital, Guildford, UK
224 rdf:type schema:Organization
225 https://www.grid.ac/institutes/grid.419619.2 schema:alternateName Janssen (Belgium)
226 schema:name Janssen Pharmaceutica NV, Beerse, Belgium
227 rdf:type schema:Organization
228 https://www.grid.ac/institutes/grid.452397.e schema:alternateName European Medicines Agency
229 schema:name Janssen EMEA, London, High Wycombe, UK
230 rdf:type schema:Organization
231 https://www.grid.ac/institutes/grid.482015.a schema:alternateName Institut Sainte Catherine
232 schema:name Institut Sainte Catherine, Avignon, France
233 rdf:type schema:Organization
234 https://www.grid.ac/institutes/grid.491941.0 schema:alternateName Agaplesion Markus Hospital
235 schema:name Agaplesion Markus Hospital, Frankfurt, Germany
236 rdf:type schema:Organization
237 https://www.grid.ac/institutes/grid.5379.8 schema:alternateName University of Manchester
238 schema:name Rosemere Cancer Centre, Royal Preston Hospital & University of Manchester, Manchester, UK
239 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...